Japanese private equity company Unison Capital has agreed to purchase drugmaker Showa Yakuhin Kako for an undisclosed amount, writes Reuters. Unison Capital is to buy the business with GC Corp, a Japanese maker of dental care materials, according to Reuters.
Reuters – Japanese private equity company Unison Capital said on Wednesday it has agreed to purchase drugmaker Showa Yakuhin Kako for an undisclosed amount.
Unison Capital said in a statement that it would buy Showa Yakuhin with GC Corp, a Japanese maker of dental care materials, and that they would manage the company together. (Reporting by Junko Fujita and Chikafumi Hodo; Editing by Chris Gallagher)